title: [Prevention of intestinal dysbiosis in patients after anti-Helicobacter therapy].
abstract: This article presents a literature review of side effects of antihelikobakter therapy, as well as survey data, whose goal was to determine the efficacy and safety of normoflorins at patients after eradication therapy of peptic ulcer. It was shown that the frequency of occurrence of side effects during antihelikobakter therapy varies widely and can reach, according to different authors, from 30 to 50% of patients. In addition to allergic and toxic PE, with antibacterial agents allocate their influence on the microflora of the colon, which often leads to development of a scarce and dysbacteriosis of antibioticassociated colitis. Appointment of biodiesel of normoflorin after eradication therapy effectively suppresses clinical signs of dyspepsia as a side effect of antihelikobakter therapy enhances the effectiveness of treatment of patients and improve their quality of life.
authors.forename: A A
authors.initials: AA
authors.lastname: Masharova
authors.forename: E Iu
authors.initials: EIu
authors.lastname: Eremina
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007410:Intestinal Diseases / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D010437:Peptic Ulcer / Q000150:complications / Q000188:drug therapy; D056692:Prebiotics; D019936:Probiotics / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D056692:Prebiotics